Department of Oncology, Hospital of Chinese Medicine of Changxing County, Huzhou, 313100, China.
Department of Radiation Oncology, Zhejiang Key Lab of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
J Hematol Oncol. 2019 Jul 12;12(1):76. doi: 10.1186/s13045-019-0760-3.
Tumor metastasis is a major contributor to the death of cancer patients. It is driven not only by the intrinsic alterations in tumor cells, but also by the implicated cross-talk between cancer cells and their altered microenvironment components. Tumor-associated macrophages (TAMs) are the key cells that create an immunosuppressive tumor microenvironment (TME) by producing cytokines, chemokines, growth factors, and triggering the inhibitory immune checkpoint proteins release in T cells. In doing so, TAMs exhibit important functions in facilitating a metastatic cascade of cancer cells and, meanwhile, provide multiple targets of certain checkpoint blockade immunotherapies for opposing tumor progression. In this article, we summarize the regulating networks of TAM polarization and the mechanisms underlying TAM-facilitated metastasis. Based on the overview of current experimental evidence dissecting the critical roles of TAMs in tumor metastasis, we discuss and prospect the potential applications of TAM-focused therapeutic strategies in clinical cancer treatment at present and in the future.
肿瘤转移是导致癌症患者死亡的主要原因。它不仅受到肿瘤细胞内在改变的驱动,还受到肿瘤细胞与改变的微环境成分之间相互作用的影响。肿瘤相关巨噬细胞(TAMs)是通过产生细胞因子、趋化因子、生长因子和触发 T 细胞中抑制性免疫检查点蛋白释放来创建免疫抑制肿瘤微环境(TME)的关键细胞。TAMs 在促进癌细胞转移级联反应的同时,表现出重要的功能,并为某些检查点阻断免疫疗法提供了多个针对肿瘤进展的靶点。在本文中,我们总结了 TAM 极化的调节网络以及 TAM 促进转移的机制。基于对 TAMs 在肿瘤转移中关键作用的现有实验证据的概述,我们讨论并展望了目前和未来 TAM 靶向治疗策略在临床癌症治疗中的潜在应用。